These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 8893732

  • 1. Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage.
    Caner HH, Kwan AL, Arthur A, Jeng AY, Lappe RW, Kassell NF, Lee KS.
    J Neurosurg; 1996 Nov; 85(5):917-22. PubMed ID: 8893732
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Oral administration of an inhibitor of endothelin-converting enzyme attenuates cerebral vasospasm following experimental subarachnoid haemorrhage in rabbits.
    Kwan AL, Lin CL, Chang CZ, Winardi D, Yen CP, Wu SC, Lee KS, Kassell NF, Howng SL, Savage P, Jeng AY.
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():414S-417S. PubMed ID: 12193135
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction in isolated rat basilar artery.
    Zimmermann M, Jung CS, Vatter H, Raabe A, Seifert V.
    Acta Neurochir (Wien); 2002 Nov; 144(11):1213-9. PubMed ID: 12434178
    [Abstract] [Full Text] [Related]

  • 8. Endothelin-converting enzyme inhibitors for the treatment of subarachnoid hemorrhage-induced vasospasm.
    Lin CL, Winardi W, Jeng AY, Kwan AL.
    Neurol Res; 2006 Oct; 28(7):721-9. PubMed ID: 17164035
    [Abstract] [Full Text] [Related]

  • 9. Attenuation of experimental subarachnoid hemorrhage-induced cerebral vasospasm by CGS 26303, an endothelin-converting enzyme inhibitor.
    Kwan AL, Bavbek M, Jeng AY, Toyoda T, Kassell NF, Lee KS.
    J Cardiovasc Pharmacol; 1998 Oct; 31 Suppl 1():S320-2. PubMed ID: 9595470
    [Abstract] [Full Text] [Related]

  • 10. Contraction to big endothelin-1, big endothelin-2 and big endothelin-3, and endothelin-converting enzyme inhibition in human isolated bronchi.
    Yap EY, Battistini B, McKay KO.
    Br J Pharmacol; 2000 Jan; 129(1):170-6. PubMed ID: 10694217
    [Abstract] [Full Text] [Related]

  • 11. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.
    Wanebo JE, Arthur AS, Louis HG, West K, Kassell NF, Lee KS, Helm GA.
    Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855
    [Abstract] [Full Text] [Related]

  • 12. Alteration of basilar artery rho-kinase and soluble guanylyl cyclase protein expression in a rat model of cerebral vasospasm following subarachnoid hemorrhage.
    Wang CJ, Lee PY, Wu BN, Wu SC, Loh JK, Tsai HP, Chung CL, Kassell NF, Kwan AL.
    Biomed Res Int; 2014 Dec; 2014():531508. PubMed ID: 24982890
    [Abstract] [Full Text] [Related]

  • 13. The peptidase inhibitor CGS-26303 increases endothelin converting enzyme-1 expression in endothelial cells through accumulation of big endothelin-1.
    Raoch V, Martinez-Miguel P, Arribas-Gomez I, Rodriguez-Puyol M, Rodriguez-Puyol D, Lopez-Ongil S.
    Br J Pharmacol; 2007 Oct; 152(3):313-22. PubMed ID: 17643133
    [Abstract] [Full Text] [Related]

  • 14. The role of endothelin in experimental cerebral vasospasm.
    Roux S, Löffler BM, Gray GA, Sprecher U, Clozel M, Clozel JP.
    Neurosurgery; 1995 Jul; 37(1):78-85; discussion 85-6. PubMed ID: 8587695
    [Abstract] [Full Text] [Related]

  • 15. Plasma endothelin and big endothelin concentrations and serum endothelin-converting enzyme activity following aneurysmal subarachnoid hemorrhage.
    Juvela S.
    J Neurosurg; 2002 Dec; 97(6):1287-93. PubMed ID: 12507125
    [Abstract] [Full Text] [Related]

  • 16. Endothelin B receptor antagonists attenuate subarachnoid hemorrhage-induced cerebral vasospasm.
    Zuccarello M, Boccaletti R, Romano A, Rapoport RM.
    Stroke; 1998 Sep; 29(9):1924-9. PubMed ID: 9731620
    [Abstract] [Full Text] [Related]

  • 17. Attenuation of experimental subarachnoid hemorrhage-induced increases in circulating intercellular adhesion molecule-1 and cerebral vasospasm by the endothelin-converting enzyme inhibitor CGS 26303.
    Lin CL, Kwan AL, Dumont AS, Su YF, Kassell NF, Wang CJ, Wu SC, Kuo CL, Huang CS, Jeng AY, Liu CS.
    J Neurosurg; 2007 Mar; 106(3):442-8. PubMed ID: 17367067
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevention and reversal of vasospasm and ultrastructural changes in basilar artery by continuous infusion of CGS 35066 following subarachnoid hemorrhage.
    Kwan AL, Lin CL, Yen CP, Winardi W, Su YF, Winardi D, Dai ZK, Jeng AY, Kassell NF, Howng SL, Wang CJ.
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1069-74. PubMed ID: 16741051
    [Abstract] [Full Text] [Related]

  • 20. Attenuation of SAH-induced cerebral vasospasm by a selective ECE inhibitor.
    Kwan AL, Lin CL, Chang CZ, Wu SC, Howng SL, Jeng AY.
    Neuroreport; 2002 Feb 11; 13(2):197-9. PubMed ID: 11893909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.